Back to today’s briefing

Story perspectives

Study Reveals 11% Risk of Complications with Abortion Pill

4/29/2025

50 5

Summary

Story summary

A startling analysis shows that almost 11% of women using the abortion pill mifepristone faced serious health complications, a stark contrast to the FDA's reported rate of less than 0.5%. This study, spanning 2017 to 2023, raises urgent concerns about the underreported risks of chemical abortions, urging the FDA to reevaluate its safety measures.

1 of 1

Story summary

A startling analysis shows that almost 11% of women using the abortion pill mifepristone faced serious health complications, a stark contrast to the FDA's reported rate of less than 0.5%. This study, spanning 2017 to 2023, raises urgent concerns about the underreported risks of chemical abortions, urging the FDA to reevaluate its safety measures.